1. TORCH syndrome and TORCH screening. Lancet. 1990; 335:1559–1561. PMID:
1972489.
2. Newton ER. Diagnosis of perinatal TORCH infections. Clin Obstet Gynecol. 1999; 42:59–70. quiz 174-5. PMID:
10073301.
Article
3. Stegmann BJ, Carey JC. TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. Curr Womens Health Rep. 2002; 2:253–258. PMID:
12150751.
4. Boutall A, Urban MF, Stewart C. Diagnosis, etiology, and outcome of fetal ascites in a South African hospital. Int J Gynaecol Obstet. 2011; 115:148–152. PMID:
21798534.
Article
5. Binnicker MJ, Jespersen DJ, Harring JA. Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay. Clin Vaccine Immunol. 2010; 17:1734–1738. PMID:
20861325.
6. Jiang L, Yu Z, Tang Z, Jiang T, Zhang C, Lu Z. Protein arrays based on biotin-streptavidin system for the simultaneous detection of TORCH infections. J Nanosci Nanotechnol. 2008; 8:2286–2292. PMID:
18572639.
Article
7. Owen WE, Martins TB, Litwin CM, Roberts WL. Performance characteristics of six IMMULITE 2000 TORCH assays. Am J Clin Pathol. 2006; 126:900–905. PMID:
17074686.
Article
8. Jiang L, Yu Z, Du W, Tang Z, Jiang T, Zhang C, et al. Development of a fluorescent and colorimetric detection methods-based protein microarray for serodiagnosis of TORCH infections. Biosens Bioelectron. 2008; 24:376–382. PMID:
18524564.
Article
9. Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, Rossi R, Bistoni F, Crisanti A. Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem. 2002; 48:121–130. PMID:
11751547.
Article